Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Title
Intervention Indication Therapeutic Area Year Actions
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride) Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Tazemetostat for treating relapsed or refractory
follicular lymphoma after two therapies
Tazemetostat (E7438;EPZ-6438;Tazverik) Follicular lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Telisotuzumab vedotin for previously treated c-MET overexpressing EGFR wild-type non-squamous non-small cell lung cancer Telisotuzumab vedotin (ABBV-399;ABBV 399;ABBV399;ABT-399;Teliso-V) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tenecteplase for treating acute ischaemic stroke Tenecteplase Acute ischaemic stroke Cardiovascular System 2023 View  |  Download
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps Tezepelumab (AMG 157; MEDI9929) Nasal polyps , Rhinosinusitis Ear Nose and Throat (ENT) 2023 View  |  Download
Tiragolumab with atezolizumab and pemetrexed and carboplatin or cisplatin for previously untreated advanced non-small-cell lung cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tiragolumab with atezolizumab for oesophageal squamous cell cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Oesophageal squamous cell carcinoma Head and Neck Cancer 2023 View  |  Download
Tiragolumab with atezolizumab for treating stage III non-small cell lung cancer after platinum-based chemoradiotherapy Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tocilizumab biosimilar for treating moderate to severe active rheumatoid arthritis Tocilizumab biosimilar (Avtozma) Rheumatoid arthritis Rheumatology 2023 View  |  Download
Tolebrutinib for treating relapsing and progressive forms of multiple sclerosis Tolebrutinib (PRN-2246;SAR-442168) Multiple sclerosis (MS) Neurology 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications